West Pharmaceutical Services Inc Stock News

Conestoga Capital Advisors LLC lessened its stake in West Pharmaceutical Services, Inc. (NYSE:WST) by 13.7% in the 3rd quarter, Holdings Channel.com reports. The firm owned 87,133 shares of the medical instruments suppliers stock after selling 13,886 shares during the period. Conestoga Capital Advisors LLCs holdings in West Pharmaceutical Services were worth $36,991,000 at the end []

West Pharmaceutical (WST) could produce exceptional returns because of its solid growth attributes.

Key Companies Covered in the Parenteral Products Packaging Market Research Report Are UFP Technologies, Inc., SCHOTT AG, Gerresheimer AG, UDG Healthcare plc, West Pharmaceutical Services, Inc., SiO2 Medical Products Inc., Stevanato Group, Berry Global Inc., NIPRO EUROPE GROUP COMPANIES, Corning Incorporated,, and other key market players. Key Companies Covered in the Parenteral Products Packaging Market Research Report Are UFP Technologies, Inc., SCHOTT AG, Gerresheimer AG, UDG Healthcare plc, West Pharmaceutical Services, Inc., SiO2 Medical Products Inc., Stevanato Group, Berry Global Inc., NIPRO EUROPE GROUP COMPANIES, Corning Incorporated,, and other key market players.

I present my top 15 high-growth dividend stocks to consider during the month of December.

Robeco Institutional Asset Management B.V. reduced its position in West Pharmaceutical Services, Inc. (NYSE:WST) by 3.0% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 151,645 shares of the medical instruments suppliers stock after selling 4,715 shares during the period. []

CENTRAL TRUST Co increased its stake in West Pharmaceutical Services, Inc. (NYSE:WST) by 2.7% in the third quarter, Holdings Channel reports. The firm owned 2,105 shares of the medical instruments suppliers stock after purchasing an additional 56 shares during the period. CENTRAL TRUST Cos holdings in West Pharmaceutical Services were worth $894,000 as of its []

West Pharmaceutical Services, today''s IBD 50 Stocks To Watch, is near a buy point as the ongoing coronavirus pandemic boosts sales.

Abbott Laboratories (ABT), West Pharmaceuticals Services (WST), Baxter International (BAX) and Chemed Corporation (CHE) are high-yield dividend stocks with sustainable business models.

Alagu Subramaniam, Senior Sales Director, West Pharmaceutical Services, Asia- Pacific, shares details about the company''s contribution to the fight against COVID-19, the changing dynamics of the pharma packaging industry, technological advancements in pharma packaging and more, in an exclusive interaction with Lakshmipriya Nair The post West has been experimenting with products to build vials that are compatible with many vaccines appeared first on Express Pharma .

If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider West Pharmaceutical Services (WST).

NEXT Financial Group Inc trimmed its position in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 1.2% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,008 shares of the medical instruments suppliers stock after selling 35 shares during the period. NEXT []

Shares of West Pharmaceutical Services, Inc. (NYSE:WST) shot up 4.1% during mid-day trading on Friday . The stock traded as high as $454.42 and last traded at $451.29. 3,124 shares traded hands during mid-day trading, a decline of 99% from the average session volume of 395,772 shares. The stock had previously closed at $433.72. Several []

Veracity Capital LLC grew its stake in shares of West Pharmaceutical Services, Inc. (NYSE:WST) by 5.5% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 920 shares of the medical instruments supplier’s stock after acquiring an additional 48 shares during the […]

Marshall Wace North America L.P. purchased a new position in shares of West Pharmaceutical Services, Inc. (NYSE:WST) during the second quarter, HoldingsChannel reports. The fund purchased 1,453 shares of the medical instruments suppliers stock, valued at approximately $522,000. A number of other institutional investors and hedge funds also recently bought and sold shares of WST. []